Koichiro Hirano

887 total citations
38 papers, 730 citations indexed

About

Koichiro Hirano is a scholar working on Molecular Biology, Immunology and Pharmaceutical Science. According to data from OpenAlex, Koichiro Hirano has authored 38 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Pharmaceutical Science. Recurrent topics in Koichiro Hirano's work include Lipid Membrane Structure and Behavior (9 papers), Advancements in Transdermal Drug Delivery (5 papers) and RNA Interference and Gene Delivery (4 papers). Koichiro Hirano is often cited by papers focused on Lipid Membrane Structure and Behavior (9 papers), Advancements in Transdermal Drug Delivery (5 papers) and RNA Interference and Gene Delivery (4 papers). Koichiro Hirano collaborates with scholars based in Japan and United States. Koichiro Hirano's co-authors include C. Anthony Hunt, Eri Kanaoka, Yoshitaka Nishihara, Toshiyuki Sakaeda, Hideo Yamada, Kohsaku Kawakami, Hideo Yamada, Noriyuki Muranushi, Takayoshi Yoshikawa and Mariko Yoshida and has published in prestigious journals such as The Journal of Physical Chemistry B, Langmuir and Analytical Biochemistry.

In The Last Decade

Koichiro Hirano

38 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koichiro Hirano Japan 16 263 170 143 114 102 38 730
Hosnieh Tajerzadeh Iran 14 240 0.9× 230 1.4× 102 0.7× 83 0.7× 58 0.6× 36 792
Manisha Ramaswamy Canada 19 331 1.3× 145 0.9× 304 2.1× 292 2.6× 61 0.6× 28 1.0k
K.J. Palin United Kingdom 12 202 0.8× 323 1.9× 71 0.5× 59 0.5× 44 0.4× 22 737
Peidi Hu United States 16 292 1.1× 214 1.3× 387 2.7× 143 1.3× 70 0.7× 21 1.1k
Grace Chojnowski Australia 9 315 1.2× 69 0.4× 311 2.2× 82 0.7× 44 0.4× 10 823
Rose Hayeshi South Africa 16 269 1.0× 148 0.9× 223 1.6× 153 1.3× 64 0.6× 31 892
Sompol Prakongpan Thailand 21 152 0.6× 389 2.3× 91 0.6× 91 0.8× 28 0.3× 30 900
Tomomi Hatanaka Japan 17 172 0.7× 485 2.9× 103 0.7× 30 0.3× 60 0.6× 62 1.0k
Rishikesh M. Kulkarni United States 8 224 0.9× 502 3.0× 119 0.8× 158 1.4× 43 0.4× 10 965
Staffan Tavelin Sweden 13 293 1.1× 383 2.3× 345 2.4× 67 0.6× 50 0.5× 14 1.0k

Countries citing papers authored by Koichiro Hirano

Since Specialization
Citations

This map shows the geographic impact of Koichiro Hirano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichiro Hirano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichiro Hirano more than expected).

Fields of papers citing papers by Koichiro Hirano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichiro Hirano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichiro Hirano. The network helps show where Koichiro Hirano may publish in the future.

Co-authorship network of co-authors of Koichiro Hirano

This figure shows the co-authorship network connecting the top 25 collaborators of Koichiro Hirano. A scholar is included among the top collaborators of Koichiro Hirano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichiro Hirano. Koichiro Hirano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanaoka, Eri, et al.. (2003). Continuous Release of Interleukin-2 from Liposomal IL-2 (Mixture of Interleukin-2 and Liposomes) After Subcutaneous Administration to Mice. Drug Development and Industrial Pharmacy. 29(10). 1149–1153. 11 indexed citations
2.
Masuda, Kazuyoshi, Kazutoshi Horie, Ryuji Suzuki, Takayoshi Yoshikawa, & Koichiro Hirano. (2003). Oral-Antigen Delivery via a Water-in-Oil Emulsion System Modulates the Balance of the Th1/Th2 Type Response in Oral Tolerance. Pharmaceutical Research. 20(1). 130–134. 6 indexed citations
3.
Kanaoka, Eri, Kouji Takahashi, Takayoshi Yoshikawa, et al.. (2002). A significant enhancement of therapeutic effect against hepatic metastases of M5076 in mice by a liposomal interleukin-2 (mixture). Journal of Controlled Release. 82(2-3). 183–187. 15 indexed citations
4.
Masuda, Kazuyoshi, et al.. (2001). Evaluation of Carboxymethylpullulan as a Novel Carrier for Targeting Immune Tissues. Pharmaceutical Research. 18(2). 217–223. 16 indexed citations
5.
Kawakami, Kohsaku, Yoshitaka Nishihara, & Koichiro Hirano. (1999). Determination of the Entrapped Volume of Liposomes: Dilution Method. Analytical Biochemistry. 269(1). 139–142. 5 indexed citations
6.
Ono, Junko, Kenichi Sugita, Toshihiro Fujioka, et al.. (1999). Development of Anti-Influenza Virus Drugs I: Improvement of Oral Absorption and In Vivo Anti-Influenza Activity of Stachyflin and Its Derivatives. Pharmaceutical Research. 16(7). 1041–1046. 22 indexed citations
7.
Sakaeda, Toshiyuki & Koichiro Hirano. (1998). O/W Lipid Emulsions for Parenteral Drug Delivery. III. Lipophilicity Necessary for Incorporation in Oil Particles Even After Intravenous Injection. Journal of drug targeting. 6(2). 119–127. 22 indexed citations
8.
Hashimoto, Naofumi & Koichiro Hirano. (1998). Isomerization of Ceftibuten in Aqueous Solution. Journal of Pharmaceutical Sciences. 87(9). 1091–1096. 2 indexed citations
9.
Sakaeda, Toshiyuki, et al.. (1998). O/W Lipid Emulsions for Parenteral Drug Delivery. IV. Changes in the Pharmacokinetics and Pharmacodynamics of a Highly Lipophilic Drug, Menatetrenone. Journal of drug targeting. 6(3). 183–189. 3 indexed citations
10.
Nagata, Shunji, et al.. (1996). Absence of Lysosomal Cleavage in the Cytotoxicity Mechanism of an Immunoconjugate Composed of Anti-.ALPHA.-fetoprotein Monoclonal Antibody and Vindesine Analog.. Biological and Pharmaceutical Bulletin. 19(3). 480–483. 1 indexed citations
11.
Masuda, Kazuyoshi, et al.. (1994). Use of blue‐sepharose for purification of immunotoxin containing type 1 ribosome‐inactivating protein, gelonin. Biomedical Chromatography. 8(1). 9–13. 5 indexed citations
12.
Hashimoto, Naofumi, Toshihiro Fujioka, Kunio Hayashi, et al.. (1994). Renin Inhibitor: Relationship Between Molecular Structure and Oral Absorption. Pharmaceutical Research. 11(10). 1443–1447. 8 indexed citations
13.
Masuda, Kazuyoshi, et al.. (1994). Immunotoxins Composed of Monoclonal Antibody to α-Fetoprotein and Gelonin as a Potent Hepatoma-Targeted Drug Delivery System. Journal of drug targeting. 2(4). 323–331. 3 indexed citations
14.
Masuda, Kazuyoshi, et al.. (1993). Cytotoxicity Induced by Monoclonal Antibody to α‐Fetoprotein Coadministered with Spleen Cells of Nude Mice. Microbiology and Immunology. 37(2). 165–167. 2 indexed citations
15.
Kanaoka, Eri, et al.. (1993). Gelatin-Acacia Microcapsules for Trapping Micro Oil Droplets Containing Lipophilic Drugs and Ready Disintegration in the Gastrointestinal Tract. Pharmaceutical Research. 10(8). 1115–1122. 39 indexed citations
16.
17.
18.
19.
Hirano, Koichiro, et al.. (1982). Studies on the Absorption of Practically Water-Insoluble Drugs Following Injection VI: Subcutaneous Absorption from Aqueous Suspensions in Rats. Journal of Pharmaceutical Sciences. 71(5). 500–505. 12 indexed citations
20.
Hirano, Koichiro, et al.. (1981). Studies on the absorption of practically water-insoluble drugs following injection. II. Intramuscular absorption from aqueous suspensions in rats.. Chemical and Pharmaceutical Bulletin. 29(3). 817–827. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hosnieh Tajerzadeh Breakdown of academic impact, for papers by Manisha Ramaswamy Breakdown of academic impact, for papers by K.J. Palin Breakdown of academic impact, for papers by Peidi Hu Breakdown of academic impact, for papers by Grace Chojnowski Breakdown of academic impact, for papers by Rose Hayeshi Breakdown of academic impact, for papers by Sompol Prakongpan Breakdown of academic impact, for papers by Tomomi Hatanaka Breakdown of academic impact, for papers by Rishikesh M. Kulkarni Breakdown of academic impact, for papers by Staffan Tavelin
Rankless by CCL
2026